## KMX: CarMax, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -5.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-8.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($34.92)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. KMX Shareholder Notice: CarMax (KMX) Securities Fraud Lawsuit Filed Over Alleged Concealed Demand Pull-Forward and Auto Finance Portfolio Risk - Hagens Berman**
- Source: PR Newswire | 20251222T140840 | Bearish | Relevance: 100%
- Hagens Berman reminds investors that the Lead Plaintiff Deadline for a securities class action lawsuit against CarMax (NYSE: KMX) is January 2, 2026. The lawsuit alleges CarMax concealed a temporary "pull-forward of customer demand" and risks in its auto finance portfolio, leading to significant stock declines. Investors who suffered substantial losses are urged to contact the firm to discuss their rights.

**2. KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: PR Newswire | 20251222T090931 | Bearish | Relevance: 100%
- The Schall Law Firm is reminding investors of a class action lawsuit against CarMax, Inc. (NYSE: KMX) for alleged violations of securities laws. The lawsuit claims CarMax made false and misleading statements about its growth prospects, which were purportedly inflated by customer speculation regarding vehicle tariffs. Investors who purchased CarMax securities between June 20, 2025, and September 24, 2025, are encouraged to contact the firm before January 2, 2026.

**3. KMX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that CarMax, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: FOX 2 | 20251221T200849 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against CarMax, Inc., alleging that the company made false and misleading statements regarding its growth prospects between June 20, 2025, and November 5, 2025. Investors who suffered losses during this "Class Period" are encouraged to join the lawsuit and have until January 2, 2026, to request to be appointed as lead plaintiff. The law firm operates on a contingency fee basis, meaning investors will not incur costs unless the lawsuit is successful.

**4. Shareholders of CarMax, Inc. (KMX): Protect Your Rights Before January 2, 2026 - Contact Levi & Korsinsky**
- Source: FOX 2 | 20251221T170848 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has filed a securities class action lawsuit against CarMax, Inc. (NYSE: KMX) on behalf of investors who purchased securities between June 20, 2025, and November 5, 2025. The lawsuit alleges that CarMax overstated its growth prospects, which were temporarily boosted by tariff speculation at the beginning of the 2026 fiscal year. Shareholders are encouraged to contact Levi & Korsinsky to learn about their rights to potentially recover losses.

**5. KMX LAWSUIT ALERT: Levi & Korsinsky Notifies CarMax, Inc. Investors - Lead Plaintiff Deadline January 2, 2026**
- Source: WANE 15 | 20251221T150903 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has announced a securities class action lawsuit against CarMax, Inc. (NYSE: KMX) on behalf of investors who purchased securities between June 20, 2025, and November 5, 2025. The lawsuit alleges that CarMax overstated its growth prospects, which were temporarily boosted by speculation regarding tariffs, thus making their statements misleading. Investors who suffered losses may contact Levi & Korsinsky to learn about their rights to recover losses.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 4, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Barclays | $24 | $28 | -14% |
| 2025-12-19 | Truist Securiti | $37 | $35 | +6% |
| 2025-12-19 | B of A Securiti | $31 | $27 | +15% |
| 2025-12-19 | JP Morgan | $28 | $30 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Barclays | main | Underweight |
| 2025-12-19 | Truist Securiti | main | Hold |
| 2025-12-19 | B of A Securiti | main | Underperform |
| 2025-12-19 | JP Morgan | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-3.8%)
- Blackrock Inc.: 7.8% (+5.9%)
- State Street Corpora: 3.8% (-2.2%)
- Janus Henderson Grou: 3.3% (+1.0%)
- Diamond Hill Capital: 3.3% (-30.6%)

### Key Risks

1. Elevated short interest (11.8%): bears positioning against stock.
2. Long-term trend broken: trading 33.6% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Analyst target momentum: 4 raises (avg +9%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.57 indicates undervaluation relative to growth. Balance sheet: $1.1B free cash flow. Analyst sentiment negative (5 target cuts vs 4 raises). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.5B |
| Beta | 1.29 |
| 52W Range | $30.26 - $89.47 |
| Short Interest | 11.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.57 |
| Forward P/E | 14.7 |
| Current P/E | 14.3 |
| YoY Growth | -2.7% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 2.8% to -5.7% (-8.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.7pp (needs >3.0% for momentum thesis). Underperforming sector by 7.5pp, stock-specific weakness. Below SMA200 (0.66x), long-term trend not supportive. RSI neutral at 44. OFD pattern: -DUH (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.66% (CS: 3) | Weak |
| RSI_14 | 44.5 | Neutral |
| MACD Histogram | 0.01 | Bullish |
| vs SMA20 | 0.972x | Below |
| vs SMA50 | 0.972x | Below |
| vs SMA200 | 0.664x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $38.16
- **Stop Loss:** $34.92 (8.5% risk)
- **Target:** $41.40 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 277
- **Position Value:** $10,570.32
- **Portfolio %:** 10.57%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.32 | $0.43 | +36.1% |
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*